Cala Health announced today that it received FDA breakthrough device designation for its Cala Trio treatment for action tremors in people with Parkinson’s disease. Burlingame, Calif.-based Cala Health’s Cala Trio is FDA cleared to relieve hand tremors from essential tremor (ET), but the company is now nearing the initiation of clinical trials to evaluate the […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
CB Insights reports digital health, global healthcare investment funding records
CB Insights reported record funding for global healthcare and digital health, among other milestones during the third quarter. Global healthcare investments to private companies hit a new quarterly record of $21.8 billion in the third quarter of this year, with a total of 1,539 equity investments in the three-month period growing 18% from the previous […]
Axonics launches SNS postmarket study
Axonics Modulation Technologies (NSDQ:AXNX) announced today that it is launching a post-market clinical registry study for its r-SNM system. Irvine, Calif.-based Axonics’ implantable sacral neuromodulation (SNM) system is designed for treating urinary and bowel dysfunction with a battery life of 15 years or more. The Axonics Sacral Neuromodulation System Registry (Artistry) study is a prospective, multicenter […]
Minnetronix lands NIH grant to study spinal fluid treatment tech
Minnetronix Medical today announced that it has been awarded a National Institutes of Health (NIH) grant for continued study of its proprietary Neurapheresis cerebrospinal fluid treatment platform. Akin to hemodialysis, the Neurapheresis platform is designed to rapidly remove blood cells and their cytotoxic byproducts that are released into cerebrospinal fluid following an aneurysmal subarachnoid hemorrhage. Get […]
Rhaeos and its shunt monitor win MedTech Innovator’s 2020 global competition
MedTech Innovator announced today that wearable head shunt monitor startup Rhaeos has won its 2020 Global Competition. Rhaeos (Evanston, Ill.) won the competition and $350,000 grand prize in a virtual live audience vote at The Virtual MedTech Conference, powered by AdvaMed. The 2-year-old company’s wearable, noninvasive Flowsense device monitors ventricular shunt function for hydrocephalus patients […]
This new material could aid brain studies
Researchers are touting a new material that may help scientists learn more about neurological disorders and accelerate research for brain-machine interfaces. Three scientists from Purdue University led a study of the material at the U.S. Dept. of Energy’s Argonne National Laboratory and published results in Applied Materials and Interfaces, an American Chemical Society magazine. Get the full […]
Silk Road medical adds to executive team
Stroke treatment developer Silk Road Medical (NSDQ:SILK) announced that it appointed a new executive VP of R&D and COO. William Whealon joined as executive VP of research & development, effective immediately, while current CFO Lucas Buchanan will also operate as Silk Road’s COO, effective Oct. 1. Whealon has over two decades of experience in the industry, having […]
Siemens, Novartis team up on MS drug development
Siemens Healthineers (ETR:SHL) and Novartis (NYSE:NVS) have agreed to jointly design, develop and commercialize diagnostic tests for therapeutic products across Novartis’ therapeutic pipeline, the companies announced today. The first project will be a serum neurofilament light chain (NfL) immunoassay for patients with multiple sclerosis (MS) and other neurological diseases. Get the full story on our sister site, Drug […]
RapidAI raises $25M Series B
RapidAI announced today that it raised $25 million in a Series B financing round as it looks to accelerate global growth initiatives. Lennertz & Co. contributed the funds in the financing round, with its managing director Philipp Lennertz saying in a news release that RapidAI’s work has brought “measurable improvement” to patient care around the […]
Cala Health touts results of real-world tremor study
Cala Health today touted data demonstrating that its Cala Trio therapy is safe and effective in improving essential tremor in patients. Burlingame, Calif.-based Cala Health said in a news release that the data for the wearable technology came from use at home, unsupervised and under real-world conditions, further validating the results reported in the Prospect […]
CarThera collects $14.3M
CarThera announced today that it received a $2.3 million (€2 million) grant and $12 million (€10.5 million) in equity, totaling $14.3 million. Paris-based CarThera was selected by the EIC Accelerator Pilot to receive the funds as it develops its Domeus project for treating glioblastoma patients. In addition to the money, CarThera is also slated to […]